Global Life Sciences Cluster Report 2011 - Jones Lang LaSalle

India ranked third for inward direct investment flows. Between
2003 and 2006, just over $12 billion was invested (a figure
approximately five times the global average) and between
2007 and 2010, just under $17 billion was invested (a figure
presenting more than 5.5 times the global average). India’s
growth over the first period was more than 100 percent, yet like
other countries impacted by the global economic recession,
India saw a decline in year-to-year investment levels between
2007 and 2010. Some 47 percent of investment in India went
for R&D, one of the best research investment performances
by any of the top FDI nations.
Investment levels declined significantly outside of the top three
Asian countries. Even while some of the countries put up very
sizable percentage growth figures, the absolute dollar value
of the inward flows was a fraction of the top three countries.
(Reference, figure 8)
Europe, Middle East and Africa (EMEA)
Ten countries in the EMEA region received significant investments
in the drug and pharmaceutical sector. EMEA countries
also generally received a larger percentage of R&D investment
than those of countries in other regions.
Ireland was the largest recipient of inward direct investment in
the region, receiving more than $50 billion from 2003 to 2010.
From 2003 to 2006, Ireland received just over $37 billion in
inward flows (approximately 14 times the global average), and
between 2007 and 2010, just under $16 billion (approximately 5
11 The drug and pharmaceuticals global direct investment landscape | Jones Lang LaSalle
times the global average). Direct investment in manufacturing
facilities represented close to 90 percent of all investment in
the country, probably because of related tax incentives.
Germany was the second largest recipient in the region with
more than $25 billion in inward investment between 2003 and
2010. Like Ireland, Germany also received more investment
between 2003 and 2006 than between 2007 and 2010, but when
viewed from a global perspective, Germany received just over
five times the global average between 2003 and 2006 and just
under four times the global average between 2007 and 2010.
Most investment in Germany was in the manufacturing sector.
France was third in the region for inward investment flows,
receiving just under $23 billion between 2003 and 2010.
Between 2003 and 2006, France received just over $14 billion
in inward investment, a figure just over five times the global
average, and approximately $8.5 billion between 2007 and
2010, a figure 2.75 times the global average. R&D investment
represented just over 30 percent of total investment in France.
Spain and Italy rounded out the top five destinations for direct
investment in Europe. Spain received a significant amount of
inward investment between 2003 and 2006, but slowed notably
after 2006. Italy was the opposite.
Other countries of significance in EMEA included the United
Kingdom, Russia, Belgium, Switzerland and Sweden. While
seeing lower levels of investment than the top five, each still
received notable investment at levels generally above the
global average. Of this group of countries, at more than 30
percent, the United Kingdom, Belgium and Sweden all stood
out in terms of the total investment represented by R&D.
As a general rule, investment in the Middle East and Africa
remains very low relative to other countries in the region.
(Reference, figure 9)
2%
10% 1%
76%
Tof C
9% 1%
63%